undamentalytics Newsletter
Sign in

Biomerica Inc income statement

In fiscal 2026, Biomerica Inc reported revenue of $4.5m, down 16.2% on the year before, operating income of −$5.3m (a -119.5% margin) and net income of −$3.8m, or −$1.30 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011May 20112012May 20122013May 20132014May 20142015May 20152016May 20162017May 20172018May 20182019May 20192020May 20202021May 20212022May 20222023May 20232024May 20242025May 20252026May 2026LTMAug 2026
Revenue566555665771955544
Cost of revenue344334444571655544
Gross profit22222222120301000
Research and development00011111222221111
Selling, general and administrative11121222236665555
Operating income−011−0−1−1−1−1−2−3−7−5−7−6−5−5−5
Interest expense0000—000000——————
Income before tax—11−0−1−1−1−1−2−3−7−5−7−6−5−4−5
Income tax00−0−0−01—0000000000
Net income011−0−0−1−1−1−2−3−7−5−7−6−5−4−5
Diluted EPS$0.16$0.64$0.56−$0.24−$0.32−$1.60−$0.88−$1.36−$2.08−$2.08−$4.96−$2.88−$4.00−$2.84−$2.16−$1.30−$1.63
Diluted shares (average)——————1m1m1m1m1m2m2m2m2m3m3m
EBITDA−011−0−0−1−1−1−2−3−7−4−7−6−5−5−5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BMRA vs INBSBMRA vs CNSYBMRA vs MCTA

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Biomerica Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biomerica Inc.